BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2664200)

  • 1. Role of anaerobic bacteria in intra-abdominal septic abscesses in mediating septic control of skeletal muscle glucose oxidation and lactic acidemia.
    Vary TC; Siegel JH; Tall B; Morris JG
    J Trauma; 1989 Jul; 29(7):1003-13; discussion 1013-4. PubMed ID: 2664200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic and systemic metabolic responses to aerobic and anaerobic intra-abdominal abscesses in a highly reproducible chronic rat model.
    Nakatani T; Sato T; Marzella L; Hirai F; Trump BF; Siegel JH
    Circ Shock; 1984; 13(3):271-94. PubMed ID: 6380793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: effects on plasma lactate.
    Vary TC
    Shock; 1996 Aug; 6(2):89-94. PubMed ID: 8856841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF binding protein prevents hyperlactatemia and inactivation of PDH complex in skeletal muscle during sepsis.
    Vary TC; Hazen SA; Maish G; Cooney RN
    J Surg Res; 1998 Nov; 80(1):44-51. PubMed ID: 9790813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of the size and clone of an intra-abdominal abscess in rats.
    Nakatani T; Sato T; Trump BF; Siegel JH; Kobayashi K
    Res Exp Med (Berl); 1996; 196(2):117-26. PubMed ID: 8739801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pure or combined inocula of Escherichia coli and Bacteroides fragilis on the liver and related metabolism.
    Rink RD; Kaelin CR; Raque G; Trachtenberg LS; Fry DE
    Lab Invest; 1982 Mar; 46(3):282-7. PubMed ID: 7038296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD; Kao J; Houston K
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological reversal of abnormal glucose regulation, BCAA utilization, and muscle catabolism in sepsis by dichloroacetate.
    Vary TC; Siegel JH; Zechnich A; Tall BD; Morris JG; Placko R; Jawor D
    J Trauma; 1988 Sep; 28(9):1301-11. PubMed ID: 3418755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver.
    Vary TC; Siegel JH; Nakatani T; Sato T; Aoyama H
    Am J Physiol; 1986 Jun; 250(6 Pt 1):E634-40. PubMed ID: 3521310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peritonitis model with low mortality and persisting intra-abdominal abscesses.
    Buyne OR; Bleichrodt RP; Verweij PE; Groenewoud HM; van Goor H; Hendriks T
    Int J Exp Pathol; 2006 Oct; 87(5):361-8. PubMed ID: 16965563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal bacteria translocate into experimental intra-abdominal abscesses.
    Wells CL; Rotstein OD; Pruett TL; Simmons RL
    Arch Surg; 1986 Jan; 121(1):102-7. PubMed ID: 3510604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of polymicrobial abscesses in the poorly controlled diabetic host.
    Bessman AN; Sapico FL; Tabatabai M; Montgomerie JZ
    Diabetes; 1986 Apr; 35(4):448-53. PubMed ID: 3514325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell proliferative responses following sepsis in neonatal rats.
    Dallal O; Ravindranath TM; Choudhry MA; Kohn A; Muraskas JK; Namak SY; Alattar MH; Sayeed MM
    Biol Neonate; 2003; 83(3):201-7. PubMed ID: 12660439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD; Kao J
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots.
    Dunn DL; Rotstein OD; Simmons RL
    Arch Surg; 1984 Feb; 119(2):139-44. PubMed ID: 6365029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peritoneal environment during infection. The effect of monomicrobial and polymicrobial bacteria on pO2 and pH.
    Sawyer RG; Spengler MD; Adams RB; Pruett TL
    Ann Surg; 1991 Mar; 213(3):253-60. PubMed ID: 1998406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of live Escherichia coli and Bacteroides fragilis on metabolism and hepatic pO2.
    Rink RD; Kaelin CR; Giammara B; Fry DE
    Circ Shock; 1981; 8(5):601-11. PubMed ID: 7026081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A standardised and reproducible model of intraabdominal infection and abscess formation in rats.
    Bosscha K; Nieuwenhuijs VB; Gooszen AW; van Duijvenbode-Beumer H; Visser MR; Verweij WR; Akkermans LM
    Eur J Surg; 2000 Dec; 166(12):963-7. PubMed ID: 11152259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.